Lysat Pharma

Lysat-Pharma is a German biotechnology company specializing in the development and production of bacterial lysates for immunotherapeutic applications. The company's primary product, Resistocell, is a complex preparation derived from various bacterial strains designed to stimulate the immune system and serve as an adjunctive treatment for chronic infections and oncology. Lysat-Pharma focuses on "Lysat-Therapie," leveraging the immunomodulatory properties of bacterial components to enhance host defense mechanisms. The company operates primarily in the European market, providing specialized pharmaceutical products for integrative and biological medicine.